Experts Discuss the Role of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
CCO Oncology Podcast - A podcast by Clinical Care Options
Categories:
In this podcast based on a live symposium at the American Society of Clinical Oncology 2024 Annual Meeting, 3 experts discuss the role of CDK4/6 inhibitors in the adjuvant and metastatic setting for HR-/HER2- breast cancer.
